Who's Who Legal
Who's Who Legal
New to Who's Who Legal?
New to Who's Who Legal?
Menu
User Menu
New to Who's Who Legal?
Thought Leaders

Thought Leaders

Thought Leader

WWL Ranking: Thought Leader

Global Leader

Healthcare 2020

Professional Biography

WWL Ranking: Recommended

WWL says

Peers note that Andreas Wildi “has lots of knowledge and a background in government and pharmaceutical work”, with a particular focus on reimbursement and pricing issues.

Biography

Andreas Wildi, born in 1972, is a medical doctor and an attorney at law. He consults and represents Dow Jones and Nasdaq-listed multinational companies, as well as mid-cap and small-cap enterprises in the life sciences sector. He mainly focuses on Swiss and international reimbursement and pricing law of pharmaceuticals and other therapeutic products. Regulatory issues of pharmaceuticals, medical devices, special nutrition, cosmetics, genetic testing, stem cell and blood products are his further key areas of practice.

Andreas Wildi studied medicine at the University of Zurich and graduated as medical doctor (MD). Working part-time in a hospital and a GP practice, and on international rescue missions, he completed his law degree at the University of St Gallen HSG (MLaw). Before passing the Bar exam, he gained his first professional legal experience as clerk with the Cantonal Court of Schaffhausen and with a recognised business law firm in Zurich. From his first position as an attorney at law in a large Zurich business law firm, Andreas Wildi was asked to work for the Swiss government, where he led the pharmaceutical reimbursement and pricing unit in the Federal Office of Public Health. Thereafter, Andreas Wildi broadened his market access expertise internationally, as EMEA market access law director for Janssen Pharmaceuticals (Johnson & Johnson). Since 2012, he has built up his legal practice in a large, well-regarded Zurich business law firm. In 2015, Walder Wyss elected Andreas Wildi as partner. He lectures in pharmaceutical law at the University of Lucerne.

Andreas Wildi works in German, French and English. He is admitted to all Swiss courts.

With around 220 legal experts, Walder Wyss is one of the most successful and fastest-growing Swiss commercial law firms, with offices in Zurich, Geneva, Basel, Berne, Lausanne and Lugano. They specialise in corporate and commercial law, banking and finance, intellectual property and competition law, dispute resolution and tax law. Their clients include national and international companies, publicly held corporations and family businesses as well as public law institutions and private clients.

Life Sciences - Regulatory 2020

Professional Biography

WWL Ranking: Recommended

WWL says

Andreas Wildi is a standout name in the Swiss market. Sources highlight his specialisation in pricing and reimbursement and his experience with the regulatory authorities as notable strengths.

Biography

Andreas Wildi, born in 1972, is a medical doctor and an attorney at law. He consults and represents Dow Jones and Nasdaq-listed multinational companies, as well as mid-cap and small-cap enterprises in the life sciences sector. He mainly focuses on Swiss and international reimbursement and pricing law of pharmaceuticals and other therapeutic products. Regulatory issues of pharmaceuticals, medical devices, special nutrition, cosmetics, genetic testing, stem cell and blood products are his further key areas of practice.

Andreas Wildi studied medicine at the University of Zurich and graduated as medical doctor (MD). Working part-time in a hospital and a GP practice, and on international rescue missions, he completed his law degree at the University of St Gallen HSG (MLaw). Before passing the Bar exam, he gained his first professional legal experience as clerk with the Cantonal Court of Schaffhausen and with a recognised business law firm in Zurich. From his first position as an attorney at law in a large Zurich business law firm, Andreas Wildi was asked to work for the Swiss government, where he led the pharmaceutical reimbursement and pricing unit in the Federal Office of Public Health. Thereafter, Andreas Wildi broadened his market access expertise internationally, as EMEA market access law director for Janssen Pharmaceuticals (Johnson & Johnson). Since 2012, he has built up his legal practice in a large, well-regarded Zurich business law firm. In 2015, Walder Wyss elected Andreas Wildi as their partner. He lectures in pharmaceutical law at the University of Lucerne.

Andreas Wildi works in German, French and English. He is admitted to all Swiss courts.

With 200 lawyers, Walder Wyss is one of the most successful and fastest growing Swiss commercial law firms, with offices in Zurich, Geneva, Basel, Berne, Lausanne and Lugano. They specialise in corporate and commercial law, banking and finance, intellectual property and competition law, dispute resolution and tax law. Their clients include national and international companies, publicly held corporations and family businesses as well as public law institutions and private clients.

National Leader

Switzerland - Life Sciences 2020

Professional Biography

WWL Ranking: Recommended

WWL says

Andreas Wildi is “fantastic” with formidable expertise on therapeutic products and the pricing laws of pharmaceuticals.

Biography

Andreas Wildi, born in 1972, is a medical doctor and an attorney at law. He consults and represents Dow Jones and Nasdaq-listed multinational companies, as well as mid-cap and small-cap enterprises in the life sciences sector. He mainly focuses on Swiss and international reimbursement and pricing law of pharmaceuticals and other therapeutic products. Regulatory issues of pharmaceuticals, medical devices, special nutrition, cosmetics, genetic testing, stem cell and blood products are his further key areas of practice.

Andreas Wildi studied medicine at the University of Zurich and graduated as medical doctor (MD). Working part-time in a hospital and a GP practice, and on international rescue missions, he completed his law degree at the University of St Gallen HSG (MLaw). Before passing the Bar exam, he gained his first professional legal experience as clerk with the Cantonal Court of Schaffhausen and with a recognised business law firm in Zurich. From his first position as an attorney at law in a large Zurich business law firm, Andreas Wildi was asked to work for the Swiss government, where he led the pharmaceutical reimbursement and pricing unit in the Federal Office of Public Health. Thereafter, Andreas Wildi broadened his market access expertise internationally, as EMEA market access law director for Janssen Pharmaceuticals (Johnson & Johnson). Since 2012, he has built up his legal practice in a large, well-regarded Zurich business law firm. In 2015, Walder Wyss elected Andreas Wildi as their partner. He lectures in pharmaceutical law at the University of Lucerne.

Andreas Wildi works in German, French and English. He is admitted to all Swiss courts.

With around 220 legal experts, Walder Wyss is one of the most successful and fastest growing Swiss commercial law firms, with offices in Zurich, Geneva, Basel, Berne, Lausanne and Lugano. The firm specialises in corporate and commercial law, banking and finance, intellectual property and competition law, dispute resolution and tax law. Clients include national and international companies, publicly held corporations and family businesses as well as public law institutions and private clients.

Law Business Research
Law Business Research Ltd
Meridian House, 34-35 Farringdon Street
London EC4A 4HL, UK
© Law Business Research Ltd 1998-2020. All rights reserved.
Company No.: 03281866